Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-13
1996-06-04
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546141, C07D21538, A61K 3147
Patent
active
055233058
ABSTRACT:
Novel composition represented by the formula: ##STR1## wherein ring A and ring B each means a benzene ring which may be substituted; R means a hydrogen atom or an alkyl group which may be substituted; R.sup.1 means a hydrogen atom or an alkyl group which may be substituted; R.sup.2 means a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted, or R.sup.1 and R.sup.2, taken together with the adjacent nitrogen atom, jointly form a ring which may be substituted, or a pharmaceutically acceptable salt thereof which is a useful tachykinin receptor antagonist.
REFERENCES:
patent: 2647902 (1953-08-01), Aschner
patent: 2809969 (1957-10-01), Speeter
patent: 3247212 (1966-04-01), Johnson
patent: 3600394 (1971-08-01), Coyne
patent: 3980655 (1976-09-01), Kunstmann
Doi Takayuki
Natsugari Hideaki
Shirafuji Hideo
Geist Gary
Kilby Scalzo Catherine
Takeda Chemical Industries Ltd.
LandOfFree
Tachykinin receptor antagonists, isoquinolones and their product does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tachykinin receptor antagonists, isoquinolones and their product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tachykinin receptor antagonists, isoquinolones and their product will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383525